Actively Recruiting
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Led by The Institute of Molecular and Translational Medicine, Czech Republic · Updated on 2026-02-12
480
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
Sponsors
T
The Institute of Molecular and Translational Medicine, Czech Republic
Lead Sponsor
N
National Institute for Cancer Research, Czech Republic
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.
CONDITIONS
Official Title
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women diagnosed with cervical cancer or high-grade cervical intraepithelial lesions (HSIL)
- Men and women diagnosed with oropharyngeal cancer
- Patients who agree to participate and sign informed consent
You will not qualify if you...
- No exclusion criteria are set
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Olomouc
Olomouc, Czechia, 77900
Actively Recruiting
Research Team
M
Marian Hajduch, MD., PhD.
CONTACT
V
Vladimira Koudelakova, MSc, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here